|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 113 IDR | -4.24% |
|
-14.39% | -90.13% |
| May. 10 | Foreign Investment Review Board Clears Probiotec Acquisition by Pyridam Farma | MT |
| Mar. 15 | PT Pyridam Farma Tbk Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
PT Pyridam Farma Tbk reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was IDR 307,111.03 million compared to IDR 222,508.93 million a year ago. Net income was IDR 9,051.65 million compared to IDR 11,365.63 million a year ago.
Basic earnings per share from continuing operations was IDR 16.92 compared to IDR 21.24 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -90.13% | 77.91M | |
| +42.69% | 749B | |
| +34.11% | 605B | |
| -6.87% | 351B | |
| +18.74% | 328B | |
| +6.76% | 292B | |
| +18.08% | 248B | |
| -3.44% | 214B | |
| +11.35% | 216B | |
| +2.64% | 167B |
PT PYRIDAM FARMA TBK 
